An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Ain Shams University, Faculty of medicine, Cairo, Egypt
University of California, Irvine, Orange, California, United States
Gangnam Severance Hospital, Seoul, Korea, Republic of
Maimonides Medical Center, Brooklyn, New York, United States
Mansoura University Hospitals, Mansoura, Aldakahlia, Egypt
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Emad Zarief Kamel Said, Assiut, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.